Why Do Some Peptides Have Brand Names While Others Do Not?

When exploring peptide research, you may notice that some compounds are widely recognised by commercial brand names, while others are known only by their scientific or research names. This often leads to the question: why do some peptides have brand names and others do not?

The answer lies in where the compound is within the scientific and regulatory process.

Scientific Research Comes First

Every peptide begins as a subject of scientific investigation. During the early stages of research, compounds are commonly identified using laboratory development codes or scientific names. Researchers use these names in published studies, conference presentations and scientific discussions to ensure consistency across the research community.

At this stage, a peptide does not have a commercial brand name because it is still being investigated.

International Scientific Names

As research progresses, many compounds receive an International Nonproprietary Name (INN). This is the internationally recognised scientific name assigned so that researchers, healthcare professionals and regulators around the world can refer to the same compound using consistent terminology.

Examples include:

• Tirzepatide
• Semaglutide
• Liraglutide

These names are used throughout scientific publications and regulatory documents.

When Does a Brand Name Appear?

A brand name is created for an authorised medicinal product. Pharmaceutical companies develop commercial names to identify their products within the healthcare system and marketplace.

The brand name belongs to the finished medicine rather than to the peptide itself.

For example:

• Tirzepatide is the scientific name, while Mounjaro® and Zepbound® are brand names for authorised medicines containing Tirzepatide.
• Semaglutide is the scientific name, while Ozempic®, Wegovy® and Rybelsus® are brand names for authorised medicines containing Semaglutide.

Why Don’t Research Peptides Usually Have Brand Names?

Many peptides discussed in laboratory research remain known by their scientific or research names because they are described within scientific literature rather than marketed as authorised medicines.

Researchers therefore commonly encounter names such as BPC-157, TB-500, MOTS-c, GHK-Cu, SS-31 and Retatrutide in journals and conference presentations.

Why Understanding This Matters

Knowing whether you are reading a scientific name or a brand name makes it much easier to interpret research articles, regulatory announcements and educational resources.

It also helps explain why the same compound may appear under different names depending on whether you are reading a scientific journal, a regulatory document or information about an authorised medicine.

As peptide science continues to develop, understanding the relationship between research names, international scientific names and commercial brand names provides valuable context for anyone interested in molecular biology, biomedical research and peptide science.